Delivery Order SPE2DB22D1202-SPE2DB25FVAN8

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.46, is for the delivery of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The contract has a firm fixed price pricing type and a completion date of November 22, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,286,403 units of cefazolin, an antibiotic medication, with a ceiling value of $7,780.50. The contract is a firm fixed-price type with a period of performance through May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,924,778 units of Cefazolin 2 G/50 ML-Dextroses, a type of antibiotic medication. The order has a ceiling value of $1,445.28 and is a firm fixed-price contract. The ultimate completion date for this delivery order is September 25, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,445.28 firm fixed price contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication, with a performance period through November 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $1,187.46 and an ultimate completion date of May 23, 2024. The contract is a firm fixed-price delivery order and does not have a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,529.24, is for the supply of Cefazolin 2 g/50 ml-Dextroses, a type of antibiotic medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication, to support military treatment facilities and other federal healthcare providers. The contract has a ceiling value of $4,335.84 and an ultimate completion date of August 13, 2024. It is a firm fixed-price contract, with no set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Cefazolin 2 g/50 mL-dextrose medication. The contract has a ceiling value of $2,123.62 and is a firm fixed-price delivery order that runs through August 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of cefazolin 2 g/50 ml-dextroses, a critical care medication, with a ceiling value of $21,285.04 and a completion date of September 12, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cefazolin 2 G/50 ML-Dextroses, with a ceiling value of $2,457.12 and a period of performance through May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVAN8
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a prescription antibiotic medication, with a ceiling value of $1,228.56 and a performance period ending on May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/21/25, 9:56 AM